UnitedHealth Shares Fall 12% After Q4 Revenue Miss and Lower 2026 Guidance
UnitedHealth reported Q4 EPS of $2.11 versus $2.10 consensus and revenue of $113.215 billion against $113.817 billion estimates, while projecting fiscal-2026 revenue of over $439 billion versus analysts’ $454.6 billion forecast. Shares have fallen 12% since January, yet options skew remains calm near spot, presenting a contrarian trade opportunity.
1. Q4 Earnings and Guidance
UnitedHealth delivered Q4 EPS of $2.11, narrowly topping the $2.10 consensus, but posted revenue of $113.215 billion versus $113.817 billion expected. The company projected fiscal-2026 revenue of over $439 billion, falling short of the $454.6 billion analysts had anticipated.
2. Year-to-Date Stock Performance
Shares have declined by roughly 12% since the start of January, reflecting investor concerns over the revenue miss and reduced fiscal-2026 outlook.
3. Options Implied Volatility Skew
Analysis of the March 20 options chain reveals a relatively symmetrical volatility skew with a modestly extended right wing, indicating that smart money is hedging but not panicking on downside risk. Elevated put IV at higher strikes suggests synthetic shorts, while calm near-spot IV points to a potential contrarian entry.
4. Expected Move and Trading Opportunities
Black-Scholes calculations anticipate a one-standard-deviation trading range of $271.33 to $309.21 by the March expiration, implying a 68% probability of trading within these bounds. The combination of guided revenue miss and option-implied calm volatility may offer a contrarian trading opportunity for investors seeking directional edge.